Table 2.
Initial treatment, BMMSC treatment, and follow-up
Case | Initial treatment | MSCS treatment (IT/IA/IV) | 3 months (CSF) | 6 months (MRI/CSF) | 12 months (MRI/CSF) | 24 months (MRI/CSF) |
---|---|---|---|---|---|---|
1 | Prednisone | IT+IA | Negative | MRI negative | ||
2 | Prednisone | IT+IA | Positive | MRI negative CSF negative |
||
3 | Prednisone Cytarabine |
IT+IA | Negative | MRI better CSF negative |
||
4 | Prednisone | IT+IV after 1 year also IT+IA | Negative | MRI negative | MRI negative CSF negative |
MRI negative CSF negative |
5 | Prednisone Cytarabine |
IT+IV | Negative | MRI better | MRI unchanged CSF negative |
MRI unchanged CSF negative |
6 | Prednisone, PB, levetiracetam | IT+IV | Negative | MRI unchanged | ||
7 | Prednisone, PB | IT+IV | Negative | MRI negative | ||
8 | Prednisone, PB, levetiracetam, cytarabine | IT+IV | Negative | MRI negative |